Parameter | Value |
---|---|
Number of patients | 82 |
Age (mean ± SD) | 60.3 ± 13.0 |
Gender (male/female) | 41/41 |
MPA/GPA | 68/14 |
Initial serum creatinine (μmol/l) (median (IQR)) | 321.0 (176.8, 637.3) |
eGFR (ml/minute/1.73 m2)a (median (IQR)) | 13.86 (6.51, 27.85) |
Dialysis dependent at presentation | 30 (36.6 %) |
Urinary protein (g/24 hours) (mean ± SD) | 1.95 ± 1.56 |
Skin rash | 10 (12.2 %) |
Arthralgia | 26 (31.7 %) |
Muscle pain | 19 (23.2 %) |
Pulmonary involvement | 56 (68.3 %) |
Ear, nose, and throat involvement | 38 (46.3 %) |
Ophthalmic involvement | 16 (19.5 %) |
Gastrointestinal involvement | 17 (20.7 %) |
Nervous system involvement | 15 (18.3 %) |
BVAS (mean ± SD) | 21.1 ± 5.6 |
Hemoglobin (g/dl) (mean ± SD) | 9.1 ± 1.9 |
ESR (mm/1 hour) (mean ± SD) | 77.2 ± 39.9 |
Glomerular lesions (%) | Â |
 Total crescents (mean ± SD) | 54.1 ± 28.3 |
 Cellular crescents (mean ± SD) | 42.0 ± 26.7 |
 Fibrous crescents (median (IQR)) | 3.9 (0, 15.9) |
Tubulointerstitial lesions | Â |
 Tubular atrophy (−/+/++) | 6/59/17 |
 Interstitial infiltration (−/+/++/+++) | 1/19/57/5 |
 Interstitial fibrosis (−/+/++) | 16/58/8 |